Department of Chemistry & Nanoscience Consecutively Selected for Government-funded Projects
- 작성처
- Date2024.06.10
- 23156
Department of Chemistry & Nanoscience Consecutively Selected for Government-funded Projects
Research teams from the Department of Chemistry and Nanoscience were consecutively selected for government-funded projects, showcasing their excellent research capabilities.
Professor Juyoung Yoon from the Department of Chemistry and Nanoscience was selected for the Nano and Material Technology Development project (pioneering) by the Ministry of Science and ICT. His project will focus on non-pharmacological human-derived nanotherapeutic technology for refractory cancer treatment, aiming to develop magnetic and ultrasound-targeted nanotherapeutics for synergistic non-pharmacological immunotherapy against refractory cancer.
This research team, led by Ewha Womans University with the participation of partner institutions such as Korea University, Yonsei University, the Korea Institute of Science and Technology (KIST), and the Korea Institute of Materials Science (KIMS), will receive a total of KRW 4.8 billion in research funding over four years and nine months (three years + two years). The research team consisting of five institutions will conduct research aimed at developing safe nanotherapeutics through the reversible binding of human-derived materials and creating materials for non-pharmacological anticancer effects using magnetic/ultrasound physical targeting to treat fibrotic refractory cancers.
Professor Sun-Shin Cha from the Department of Chemistry and Nanoscience was selected for the Bio-Medical Technology Development project operated by the Ministry of Science and ICT. He will receive approximately KRW 2.6 billion in funding until 2028 to develop original technology for retrobiosynthesis with the aim of designing and producing next-generation therapeutic candidates.
The Ewha research team, in collaboration with teams from Seoul National University (the lead research institution), KAIST, Inha University, Konkuk University, and Kangwon National University, will select six bioactive target compounds with different mechanisms of action, and use retrobiosynthesis technology to attempt the structural diversification of new derivatives. The Ewha research team will study the mechanisms of bioactive secondary metabolites derived from microorganisms and plants by structure-based elucidation of the interactions between target proteins and new therapeutic candidate compounds with the ultimate goal of developing new therapeutic candidates that exhibit optimal activity and minimal toxicity, surpassing the efficacy of the original compounds.
Meanwhile, the Center for Hybrid Interfacial Chemical Structure, led by Professor So-Jung Park from the Department of Chemistry and Nanoscience, was recently selected for a follow-up project under the 2024 Support Program for Global Leading Research Center by the National Research Foundation of Korea. Established to study interfacial phenomena in chemical materials, the center has been conducting research on chemical and electronic structural interactions in hybrid compound interfaces since its designation as a Leading Research Center supported by the Ministry of Science and ICT and the National Research Foundation of Korea in 2017. Through this follow-up project, the center plans to enhance the complexity of chemical materials and develop meta-properties rarely seen in nature.
The Center for Future Sustainable Molecular Design Research at the Department of Chemistry and Nanoscience was selected for the “Ewha Frontier 10-10 Project” in leading research fields aimed at fostering a creative research ecosystem. The center focuses on developing advanced materials and nano-molecular science in the energy, environment, and bio-health sectors. To this end, the center conducts joint research systematically with world-renowned scholars to develop essential original technologies for a sustainable future society and leads key research areas that ensure the nation’s future competitiveness, thereby establishing itself as a world-class research group.